Retatrutide · The New England journal of medicine
Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply.
2023 Oct 26
Open attributed record →PubMed attributed publication year
16 selected PubMed bibliographic records with an attributed publication year of 2023. This is selective bibliographic coverage, not a complete literature review or an assessment of the articles’ findings.
16 selected records.
7 connected profiles.
14 distinct venues.
Attributed bibliography
Retatrutide · The New England journal of medicine
2023 Oct 26
Open attributed record →Retatrutide · The New England journal of medicine
2023 Oct 26
Open attributed record →Retatrutide · The New England journal of medicine
2023 Oct 26
Open attributed record →GHK-Cu · Pharmaceutics
2023 10 18
Open attributed record →GHK-Cu · The Journal of organic chemistry
2023 10 13
Open attributed record →Glucagon · Molecular and cellular endocrinology
2023 09 07
Open attributed record →Linaclotide · The Medical letter on drugs and therapeutics
2023 Aug 21
Open attributed record →Glucagon · Diabetologia
2023 06 27
Open attributed record →Elamipretide · Future cardiology
2023 06 16
Open attributed record →Octreotide · Journal of drug targeting
2023 05 23
Open attributed record →Elamipretide · Orphanet journal of rare diseases
2023 04 11
Open attributed record →Elamipretide · GeroScience
2023 02 25
Open attributed record →MOTS-c · Diabetes & metabolism journal
2023 02 24
Open attributed record →MOTS-c · Frontiers in medicine
2023 02 08
Open attributed record →MOTS-c · Ginekologia polska
2023
Open attributed record →MOTS-c · Current protein & peptide science
2023
Open attributed record →